Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G1EA
|
|||
| Former ID |
DIB012720
|
|||
| Drug Name |
SLP vaccine
|
|||
| Synonyms |
Cervical cancer vaccine, Leiden University Medical Center; SLP vaccine (cervical cancer); SLP vaccine (cervical cancer), Leiden University Medical Center; Synthetic long peptide vaccine (cervical cancer), Leiden University Medical Center
Click to Show/Hide
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0] | Phase 1/2 | [1] | |
| Company |
Leiden University Medical Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer. Oncotarget. 2015 Oct 13;6(31):32228-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.